Episode
Preeclampsia Test Helps Extend Pregnancy to Improve Outcomes
- Podcast
- Answers from the Lab
- Published
- Mar 19, 2026
- Duration seconds
- 1053
- Processing state
not_requested- Canonical source
- https://share.transistor.fm/s/6a4a6aa5
Actions
POST https://stenobird.com/v1/public/podcasts/answers-from-the-lab-870296/episodes/preeclampsia-test-helps-extend-pregnancy-to-improve-outcomes/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/answers-from-the-lab-870296/preeclampsia-test-helps-extend-pregnancy-to-improve-outcomes.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D. , president and CEO of Mayo Clinic Laboratories, to share industry updates and Mayo Clinic’s test development success in 2025. Later, Dr. Pritt welcomes Janelle Santos, M.D. , a maternal-fetal medicine specialist at Mayo Clinic, to discuss how she uses a preeclampsia test to care for her patients. Public policy insights for 2026 (00:34): Dr. Bill Morice shares insights on reimbursement and AI-related policy developments following an association meeting in Washington, D.C. An unprecedented year for test development (04:45) : Discover how Mayo Clinic’s record year for test development delivers value to Mayo Clinic’s patients and Mayo Clinic Laboratories’ clients. Novel preeclampsia testing (08:13) : Learn how new clinical testing helps physicians improve outcomes for women at risk for preeclampsia and their babies. Note: Information in this post was accurate at the time of its posting. Resources 4 steps to establishing a new approach to innovation Innovation beyond the bench: Translating science into better diagnostics and outcomes Preeclampsia: Empowering confident decision-making through preeclampsia risk assessment Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D. Preeclampsia sFlt-1/PIGF Ratio, Serum (Mayo ID: PERA)